Caredx appoints john w. hanna as its new president and chief executive officer

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna) – the transplant company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients – has appointed john w. hanna as its new president and chief executive officer, and member of the company's board of directors, effective april 15, 2024. “john is an outstanding leader with a proven track record of building.
CDNA Ratings Summary
CDNA Quant Ranking